484 related articles for article (PubMed ID: 34235155)
1. Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.
Lei MML; Lee TKW
Front Cell Dev Biol; 2021; 9():692940. PubMed ID: 34235155
[TBL] [Abstract][Full Text] [Related]
2. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
3. Immune evasion by cancer stem cells.
Tsuchiya H; Shiota G
Regen Ther; 2021 Jun; 17():20-33. PubMed ID: 33778133
[TBL] [Abstract][Full Text] [Related]
4. Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells.
Chung KPS; Leung RWH; Lee TKW
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202411
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of
Li Z; Zhang W; Bai J; Li J; Li H
Front Oncol; 2022; 12():862462. PubMed ID: 35795038
[No Abstract] [Full Text] [Related]
6. Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.
Mukherjee S; Chakraborty S; Basak U; Pati S; Dutta A; Dutta S; Roy D; Banerjee S; Ray A; Sa G; Das T
Discov Oncol; 2023 Dec; 14(1):220. PubMed ID: 38038865
[TBL] [Abstract][Full Text] [Related]
7. Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy.
Borlongan MC; Saha D; Wang H
Stem Cell Rev Rep; 2024 Jan; 20(1):3-24. PubMed ID: 37861969
[TBL] [Abstract][Full Text] [Related]
8. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
[TBL] [Abstract][Full Text] [Related]
9. Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies.
An J; Hu X; Liu F
Front Oncol; 2023; 13():1114621. PubMed ID: 36910604
[TBL] [Abstract][Full Text] [Related]
10. Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
Vahidian F; Duijf PHG; Safarzadeh E; Derakhshani A; Baghbanzadeh A; Baradaran B
Immunol Lett; 2019 Apr; 208():19-29. PubMed ID: 30862442
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment.
Sipos F; Műzes G
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672697
[TBL] [Abstract][Full Text] [Related]
12. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
[TBL] [Abstract][Full Text] [Related]
13. Hide-and-seek: the interplay between cancer stem cells and the immune system.
Sultan M; Coyle KM; Vidovic D; Thomas ML; Gujar S; Marcato P
Carcinogenesis; 2017 Feb; 38(2):107-118. PubMed ID: 27866156
[TBL] [Abstract][Full Text] [Related]
14. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor.
Becerril-Rico J; Alvarado-Ortiz E; Toledo-Guzmán ME; Pelayo R; Ortiz-Sánchez E
Stem Cell Res Ther; 2021 Sep; 12(1):498. PubMed ID: 34503571
[TBL] [Abstract][Full Text] [Related]
15. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
Zheng X; Yu C; Xu M
Front Oncol; 2021; 11():678333. PubMed ID: 34262865
[TBL] [Abstract][Full Text] [Related]
16. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
17. Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response.
Huang JL; Chen SY; Lin CS
J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455671
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal relationship between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and therapeutic strategies.
Ding G; Yu H; Jin J; Qiao X; Ma J; Zhang T; Cheng X
Future Oncol; 2024 Feb; 20(4):215-228. PubMed ID: 38390682
[TBL] [Abstract][Full Text] [Related]
20. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
